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Introduction
Ganoderma lucidum, a mushroom of biomedical importance, contains a number of bioactive components biological
response modifiers, which activate our immune systems for a multitude of defensive functions. These identified
compounds (polysaccharides and triterpenes) of known molecular structures account for a range of reported beneficial
biomedical effects, most notably in the prevention of physiological disorders and diseases.
Bioactive mycelial polysaccharides differ from the ones isolated from the fruiting body in Ganoderma species (Kim er
al., 1993; Mizuno, 1992; Sohn, (995). These two growth stages produce some similar types but different forms of
bioactive components derived form different stages of primary (polyglycans) or secondary (triterpenes) fungal
metabolites. .
In Malaysia, There is an appalling paucity of information in Malaysia on the efficacy of our own Ganoderma products.
Thus, it is only obvious that there is notable discrepancy with the public's frequent impression that Ganoderma is a
wonderful health supplement which may be taken as a cure for so many life-threatening illnesses and the lack of
experimental and clinical trials be conducted locally in order to evaluate and ascertain the quality of our local products.
Tong et al. (1994a; 1994b) recommended the use of Ganoderma mycelium in addition to the fruiting bodies for the
manufacture of the Ganoderma products. "Ganocelium" with the product number of FM0002, is the recent product in
Malaysia using mycelium of G. lucidum as its source.
Hence, this work attempts to investigate the efficacy of the water soluble extract from G. lucidium fruiting body and
mycelium grown in soy waste on (a) the levels of plasma lipids, lipoproteins and related enzymes in rats. (b)
cholesterol induced cardio-atherosclerosis, hepatic and renal functions in rats, (c) the cytotoxic activity on mouse
myeloma, leukaemia and human breast cancer cell-line, (d) changes of lipid peroxidation and antioxidant enzymes in
rats fed with a cholesterolemic diet and (e) skin and lung tumor induced by Bap in rats.
Materials and Methods
Source of microorganism: Ganoderma lucidum strain 021.
Cultivation techniques: Fungal mycelium either grown in solid soy waste as substrate for 2Y. months in sterile plastic
bags
at 28°C or soy bean extract in medical flat bottles at 25°C.
Experimental Animals : Twenty-four Male Sprague-Dawley rats weighing 300-350 g (six months old) were divided
into
four groups comprising of 6 rats per group. The formula diet for each group was planned (not shown). At regular
interval,
blood samples were collected via transecting the tail or intra-cardiac puncture and analyzed for various enzymatic
and
vitamin parameters. Histology of the liver and kidney were also examined.
Cell cultures: Balb/C mouse myeloma, J558 (ATCC); Human breast ductal carcinoma, MDA-MB-435 (ATCC);
Leukemia
cell-line, PN6/CEM-SS (National Cancer Institute, USA); and Mouse fibroblast normal cell-line, 3T3 (RIKEN Cell
Bank,
Japan).
Enzymatic analysis : Serum cholesterol and related enzymes levels were quantified using an Cobas Intrega
Multipurpose
Auto-analyser machine.
Fruiting body and mycelial extraction: Hot water and methanol extraction.
Determination of cellular growth: Microculture Tetrazolium Assay (MTT), Scanning Electron Microscopy (SEM),
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Transmission Electron Microscopy (TEM), Acridine Orange and Propidium Iodide Staining, DNA Fragmentation
Assay.
Results and Discussion
The in vivo and in vitro effect of a locally grown G. lucidum fruiting body powder (GF) and G. lucidum mycelium
(GM) grown in soy waste on tumor and hyper-cholesterolaemic rats were studied.
Administration of 1% cholesterol diet in the cholesterol (Chol) group caused a significant (p<O.05) increase in
the serum total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDL-C) levels while
reducing serum high density lipoprotein cholesterol (HDL-C) level. In the case of the Chol+GF and Chol+GM groups,
the initial serum TC, TG and LDL-C levels showed a much higher levels (p<0.05) compared to the Chol group.
However, the levels gradually decreased towards the end of the experiment. There was no significant difference in the
lipid profiles amongst the Control, GF and GM groups. Serum alanine transferase (ALT), gamma glutamyltransferase
(GGT) and creatine kinase (CK) in the Chol+GF group as well as the ALT, GGT level in the Chol+GM group were
found to be significantly (p<0.05) lower than those in the Chol group for both the experiments using GF and GM.
Despite the fact that all groups showed levels of serum urea and creatinine within the normal range, mild degenerative
changes in the glomeruli were seen in the Chol group. In addition, higher level of serum uric acid was observed in the
Chol group compared to the Chol+GF and Chol+GM groups. In term of the lipid peroxidation and antioxidant enzymes
analyses, the Chol+GF and ChoI+GM groups showed a significantly (p<0.05) lower level of malon dial dehyde (MDA),
catalase and glutathione peroxidase (GSH-Px) activities but higher vitamin C level compared to the Chol group.
The anti-carcinogenesis test indicated that hypercholesterolaemic rats (the Chol group) demonstrated a
significantly (p<0.05) higher serum MDA level as compared to the GF and Chol+GF groups. Furthermore, Ganoderma
supplemented groupS had significantly (p<O.05) lower levels of serum MDA, catalase, GSH-Px and GGT activities but
higher in the ascorbic acid level as compared to the Chol group. Histological, the Chol+GF group showed a much
reduced thickened coronary vessel wall as well as normal hair growth in the anti-carcinogenesis test. The Chol+GM
group registered 61.9% normal hepatocytes as compared to only 5.6% in the Chol group. The presence of epithelization
of lung epithelium in the Chol group which were not severe in the Chol+GM group indicated the anti-tumor effect of
IO%GM.
The cytotoxicity effect of the various Ganoderma crude extracts on MDA-MB-435 cell lines was determined
by measuring the cytotoxic dose that killed 50% of the cell population in 72 hours as compared to the untreated control.
The mycelial results obtained from G. lucidum was the most effective towards MDA-MB-435 with an IC50 value of
148 ± 9.07 JlglmL.
The percentage viability of MDA-MB-435 cells exposed to Ganoderma crude extracts was dose-dependent
and there was significant reduction when the dose was increased to 400Jlglml. Under the phase contrast microscopy, a
mixture of cells in necrosis and apoptosis was apparent. Apoptotic bodies and cells with condensed nuclei were
conspicuous as representative of typical morphology of apoptotic death mode. Necrotic cells were seen as rupture cells
with an irregular shape due to the loss of membrane integrity. In this case, these cells were detached from basement and
remained floating in the medium. The fluorescence microscopic examination of MDA-MB-435 cells treated with
commercial G. lucidum powder crude extract for 24, 48 and 72 hours revealed that the percentage of apoptotic cells and
necrotic cell increased significantly within 72 hours of treatment, whereas the viable cells decreased by as much as
55%. It is apparent that the mode of cell death via apoptosis is 18.4% more than necrotic. Both the scanning electron
micrograph and the transmission electron micrographs further confirmed the Ganoderma powder crude extract induced
MDA-MB-435 cell death by apoptosis and necrosis. _
When the cells were treated at ICso with commercial G. lucidum crude extract for 72 hours, intemucleosomal
DNA cleavage was obvious. Thus, the biochemical hallmark observed in G. lucidum treated MDA-MB-435 cells as
demonstrated by intemucleosomal DNA cleavage confirmed the apoptotic mode of cell death.
Conclusions
The effectiveness of GF and GM in inhibiting cholesterol deposition resulting in plaque and cholesterol synthesis was
indicated. The results also showed a redistribution of lipoprotein cholesterol leading to the formation of pronounced
anti-atherogenic lipoprotein profile and demonstration of antioxidant properties. G. lucidum crude extract exhibited the
highest cytotoxic activity (lower ICso) towards J558 Balb/C mouse myeloma, MDA-MB-435 human breast ductal
carcinoma, PN6 leukemia T-cell but not against 3T3 mouse fibroblast normal cell-line as compared to crude extract
from G. tsugae and G. Iropicum. Among these cancer cell-lines, J558 cells were most sensitive to the cytotoxic effects
of all the three Ganoderma spp. Furthermore, the suppressive effect of G. lucidum crude extract on LOOH formation
would partly contribute to the anti-tumor promoting activity of G. lucidum crude extract in rat skin. This pilot study
suggests the potential use of commercial G. lucidum powder and G. lucidum mycelium in the prevention of diseases
related to hypercholesterolaemia and lipid peroxidation.
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Benefits from the study
Malaysia currently imports millions of Ringgit worth of health products processed from Ganoderma annually. It is
imperative that experimental and clinical trials be conducted locally in order to evaluate and ascertain the quality of our
own local Ganoderma products. Research findings of this nature will provide sound scientific backing to the
establishment of local industries in the manufacture of high quality Ganoderma health products well supported by
scientific evaluation data. Through direct linkages and providing consultation services, the research findings will be
channeled to local potential producers/industries with the hope of establishing collaborative venture with UPM. New
information networks between local and overseas scientists laid die foundation for infrastructural development through
active participation in international conferences/seminars. This project has trained postgraduates capable. of
contributing further advancement to this area of research. A total of 4 journal papers intended for international
publication are in preparation
Patent(s), if applicable:
Nil
Stage of Commercialization, if applicable:
Nil
Project Publications in Refereed Journals:
Nil
Project Publications in Conference Proceedings
1. Tong Chow Chin. 1998. Studies of Polysaccharides from Ganoderma lucidum.ln: Proceedings of the International
Science Conference, 1998.
2. Choong Y. K. and C.C. Tong (1999). Anti-cholesterol Activities of Ganoderma Lucidum. 220<1Microbiology
Symposium and JSP-NRCT/DOST/UPINCC Seminar, 1999; p75
3. Choong, Y.K., C.C. Tong, Nor Ani B. Umar, Mohamed Suhaila and Nordin. M. Mustapha. 2000. Effect of Ganoderma
lucidum crude extract on plasma lipids, lipoproteins and related enzymes in rats. lOth Annual Scientific Meeting.
(Malaysian Association of Clinical Biochemists), 2000.
4. Choong, Y.K., Nordin. M. Mustapha, Nor Ani B. Umar, Mohamed Suhaila, and C.C. Tong. 2000. In vitro studies of
Ganoderma water extract as antitumor activities with MIT cytotoxicity test. 12th National Biotechnology Seminar,
2000.
5. Choong, Y.K., C.C. Tong, Mohamed Suhaila, Nordin. M. Mustapha.Nor and Ani B. Umar, 2000. The effects of
Ganoderma lucidum crude extract on lipid peroxidation and antioxidant enzymes in rats fed with cholesterolemic diet.
The 16111 National Seminar on Natural Products, 2000; p65
6. Choong, Y.K., C.C.Tong, Mohamed Suhaila, Nordin. M. Mustapha.Nor and Ani B. Umar. 2000. Anti-proliferative
activity of Ganoderma crude extract on mouse myeloma, leukemia and human brest cancer cell-line. The 23111
Microbiology Symposium. Langkawi, 2000; p27
7. Choong, Y.K., C.C. Tong, Nordin. M, Mohamed Suhaila., Mustapha.Nor and Ani B. Umar. 2001. A comparative study
on the cytotoxic activity of water soluble crude mycelial extracts from three Ganoderma sp. on mouse myeloma,
leukemia and human brest cancer cell-line. Proceedings of Conference on Functional Food - Latest Development, 200 I
8. Cheong, Y.K., C.C. Tong, Mohamed Suhaila, Nordin. M. Mustapha.Nor and Ani B. Umar. 2001. The effect ofG.
lucidum crude extract on benzoapyrene in hypercholesterollemic rat skin following topical application. Proceedings of
"The 13'hNational Biotechnology Seminar, 2001.
71
UPM Research Report 1997-2000. Valli. Section 2-Extended Abstracts
Graduate Research
Name of Research Topic
Graduate
Field of Degree
Awarded
GraduatioD
YearExpertise
Law Buon Jong Production
Properties
Polysaccharides
Mycelia of
Ganoderma sp.
and Mushroom
of Biotechnology
from
M.Sc 2000
Three
Choong
Keong
Yew In Vivo and In Vitro Mushroom
Studies of Anti- Biotechnology
Cholesterol and Anti-
Carcinogenic Effects of
Ganoderma Crude
Extracts
Ph.D 2003
IRPA Project numberOl-02-04-0444
UPM Research ClusterAFF
72
